Alyeska Investment Group
FLGT icon

Alyeska Investment Group’s Fulgent Genetics FLGT Stock Holding History

Alyeska Investment Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-102,185
Closed -$1.18M – 508
2016
Q4 		$1.18M Sell
102,185
-47,815
-32% -$451K 0.01% 419
2016
Q3 		$1.38M Buy
+150,000
New +$1.38M 0.01% 404

Other funds holding FLGT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SC
Scholtz & Company Stamford, Connecticut $195M AUM 12.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NFA
Nationwide Fund Advisors Columbus, Ohio $2.42B AUM 17.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alyeska Investment Group's FLGT Position: Q1 2017 in Review

Alyeska Investment Group sold out of Fulgent Genetics (FLGT) in Q1 2017, closing a stake of 102,185 shares — an estimated $1.18M sold.

Alyeska Investment Group first reported a position in FLGT in Q3 2016 and held it in 2 quarters. The position peaked at $1.38M in Q3 2016. 37 funds tracked by Wall St. Rank hold FLGT as of Q1 2017.

  • Alyeska Investment Group reported no remaining Fulgent Genetics position as of Q1 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 102,185 Fulgent Genetics shares in Q1 2017, an estimated $1.18M.
  • Alyeska Investment Group first reported a position in Fulgent Genetics in Q3 2016 and held it in 2 quarters.
  • Alyeska Investment Group's Fulgent Genetics position peaked at $1.38M in Q3 2016.
  • 37 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2017.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.